Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 5 of the 13 calendar months from Oct 2025 to Oct 2026: Mar 2026, Apr 2026, May 2026, Jun 2026 and Jul 2026.
- Largest single sale: $469K (1,104 shares) of Vertex Pharmaceuticals on May 1, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Vertex Pharmaceuticals (VRTX) | EVP and Chief Legal Officer | Mar 3, 2026 | Jul 6, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jul 1, 2026, Vertex Pharmaceuticals: sold 828 shares for $416K, under a disclosed plan. 1 filing: 1
- Jun 1, 2026, Vertex Pharmaceuticals: sold 828 shares for $364K, under a disclosed plan. 1 filing: 1
- May 1, 2026, Vertex Pharmaceuticals: sold 1,104 shares for $469K, under a disclosed plan. 1 filing: 1
- Apr 1, 2026, Vertex Pharmaceuticals: sold 978 shares for $439K, under a disclosed plan. 1 filing: 1
- Mar 2, 2026, Vertex Pharmaceuticals: sold 892 shares for $442K, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.